Table 3.
Results from Firth logistic regressions predicting vasopressor independence
| Model | OR (95% CI) | p-value |
|---|---|---|
| Primary | ||
| (Intercept) | 10.7 (0.69 to 232.8) | 0.09 |
| PC1 | 1.04 (0.93 to 1.16) | 0.54 |
| SBP | 0.977 (0.95 to 1.00) | 0.08 |
| First ancillary | ||
| (Intercept) | 0.96 (0.56 to 1.65) | 0.88 |
| PC1 | 1.02 (0.92 to 1.13) | 0.77 |
| Second ancillary | ||
| (Intercept) | 2.74 (0.53 to 15.8) | 0.23 |
| PC1 | 1.02 (0.91 to 1.14) | 0.734 |
| APACHEII | 0.96 (0.91 to 1.02) | 0.19 |
| Third ancillary | ||
| (Intercept) | 1.72 (0.85 to 3.64) | 0.13 |
| PC1 | 0.99 (0.89 to 1.11) | 0.88 |
| NEE dose | <0.001 (<0.001 to 0.17) | <0.01 |